AKT1 and cancer: It is important to mention that Oh et al. in 2017 [67] made a downregulation of GLUT1 expression in breast cancer cell, getting a decrease in cellular apoptosis, induced by an up-regulation in Akt signaling pathway, suggesting that drugs focused only on GLUT1 as a therapeutic target must be evaluated in each cancer cell type.